Tachykinin receptors as drug targets for motility disorders. 2006

Willemijntje A Hoogerwerf, and Sushil K Sarna
Department of Internal Medicine, Enteric Neuromuscular Disorders and Visceral Pain Center, Division of Gastroenterology, The University of Texas Medical Branch, Galveston, TX 77555-1064, USA.

The tachykinins and their receptors are strategically distributed within the gut wall, spinal cord, and central nervous system to be potential targets of therapeutic agents for gastrointestinal motility disorders. However, the development of effective tachykinin receptor agonists or antagonists to treat these disorders has had very limited success so far. This is, in part, due to the complex and multilevel of regulation of gastrointestinal motility function and the challenges faced in targeting the specific type of gut contraction to normalize function in disease state.

UI MeSH Term Description Entries
D005765 Gastrointestinal Agents Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. Digestants,Gastric Agents,Gastric Drugs,Gastrointestinal Drugs,Agents, Gastric,Agents, Gastrointestinal,Drugs, Gastric,Drugs, Gastrointestinal
D005767 Gastrointestinal Diseases Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Cholera Infantum,Gastrointestinal Disorders,Functional Gastrointestinal Disorders,Gastrointestinal Disorders, Functional,Disease, Gastrointestinal,Diseases, Gastrointestinal,Functional Gastrointestinal Disorder,Gastrointestinal Disease,Gastrointestinal Disorder,Gastrointestinal Disorder, Functional
D005769 Gastrointestinal Motility The motor activity of the GASTROINTESTINAL TRACT. Intestinal Motility,Gastrointestinal Motilities,Intestinal Motilities,Motilities, Gastrointestinal,Motilities, Intestinal,Motility, Gastrointestinal,Motility, Intestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001337 Autonomic Agents Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc. Autonomic Drugs,Autonomic Effect,Autonomic Effects,Agents, Autonomic,Drugs, Autonomic,Effect, Autonomic,Effects, Autonomic
D018039 Receptors, Tachykinin Cell surface proteins that bind TACHYKININS with high affinity and trigger intracellular changes influencing the behavior of cells. Three classes of tachykinin receptors have been characterized, the NK-1; NK-2; and NK-3; which prefer, respectively, SUBSTANCE P; NEUROKININ A; and NEUROKININ B. Tachykinin Receptors,Receptors, Tachykinins,Tachykinin Receptor,Receptor, Tachykinin,Tachykinins Receptors

Related Publications

Willemijntje A Hoogerwerf, and Sushil K Sarna
January 2009, Current pharmaceutical design,
Willemijntje A Hoogerwerf, and Sushil K Sarna
October 2001, European journal of pharmacology,
Willemijntje A Hoogerwerf, and Sushil K Sarna
August 2013, CNS & neurological disorders drug targets,
Willemijntje A Hoogerwerf, and Sushil K Sarna
May 1995, Regulatory peptides,
Willemijntje A Hoogerwerf, and Sushil K Sarna
June 1997, Canadian journal of physiology and pharmacology,
Willemijntje A Hoogerwerf, and Sushil K Sarna
June 2006, CNS & neurological disorders drug targets,
Willemijntje A Hoogerwerf, and Sushil K Sarna
January 2016, Nature reviews. Gastroenterology & hepatology,
Willemijntje A Hoogerwerf, and Sushil K Sarna
May 2015, Neurogastroenterology and motility,
Willemijntje A Hoogerwerf, and Sushil K Sarna
March 2017, Future medicinal chemistry,
Willemijntje A Hoogerwerf, and Sushil K Sarna
February 2008, Nature reviews. Drug discovery,
Copied contents to your clipboard!